Salima Hamizi

2.3k total citations
8 papers, 22 citations indexed

About

Salima Hamizi is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Salima Hamizi has authored 8 papers receiving a total of 22 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Reproductive Medicine and 2 papers in Molecular Biology. Recurrent topics in Salima Hamizi's work include Ovarian cancer diagnosis and treatment (5 papers), Cancer Treatment and Pharmacology (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Salima Hamizi is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Cancer Treatment and Pharmacology (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Salima Hamizi collaborates with scholars based in France. Salima Hamizi's co-authors include Gaëtan De Rauglaudre, Anne Floquet, Patricia Pautier, Marie‐Christine Kaminsky, Olivier Colomban, Isabelle Laure Ray-Coquard, Emmanuelle Malaurie, Nadine Dohollou, Benoît You and Laure Favier and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Tumori Journal.

In The Last Decade

Salima Hamizi

8 papers receiving 21 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salima Hamizi France 3 14 7 6 5 4 8 22
Cristina Churruca Spain 3 5 0.4× 5 0.7× 7 1.2× 5 1.0× 3 0.8× 8 16
S Slavcheva Bulgaria 3 6 0.4× 6 0.9× 4 0.7× 3 0.6× 2 0.5× 3 15
Stephanie Chung United States 2 6 0.4× 2 0.3× 2 0.3× 2 0.4× 3 0.8× 3 15
Aurora Taira Finland 4 5 0.4× 4 0.7× 5 1.0× 13 3.3× 6 38
Sofía Martínez Spain 3 4 0.3× 3 0.4× 4 0.7× 5 13
Cristina Costan France 2 12 0.9× 2 0.3× 12 2.0× 1 0.2× 3 16
Elizabeth T. Walsh United States 3 2 0.1× 11 1.6× 2 0.3× 5 1.0× 4 1.0× 8 22
Sylvia Richey United States 2 3 0.2× 5 0.7× 2 0.3× 5 1.3× 5 10
Nerma Resić Bosnia and Herzegovina 3 3 0.2× 3 0.4× 3 0.5× 1 0.2× 6 1.5× 7 32
Laura Mattheis Germany 3 3 0.2× 1 0.1× 6 1.0× 3 0.6× 4 1.0× 3 19

Countries citing papers authored by Salima Hamizi

Since Specialization
Citations

This map shows the geographic impact of Salima Hamizi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salima Hamizi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salima Hamizi more than expected).

Fields of papers citing papers by Salima Hamizi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salima Hamizi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salima Hamizi. The network helps show where Salima Hamizi may publish in the future.

Co-authorship network of co-authors of Salima Hamizi

This figure shows the co-authorship network connecting the top 25 collaborators of Salima Hamizi. A scholar is included among the top collaborators of Salima Hamizi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salima Hamizi. Salima Hamizi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Cătană, Andreea, Gaëtan De Rauglaudre, Nadia Raban, et al.. (2023). 793P Strong relationships between the CA-125 KELIM score and the tumor biological effects after neo-adjuvant chemotherapy in advanced ovarian cancer patients: CHIVA trial (GINECO). Annals of Oncology. 34. S532–S532. 1 indexed citations
3.
Blanc‐Durand, Félix, Elisa Yaniz‐Galende, Catherine Genestie, et al.. (2022). Immune tumor microenvironnement (iTME) post-neoadjuvant chemotherapy, beyond PD-L1: Novel immune targets in ovarian cancer, data from the CHIVA trial, a GINECO/GINEGEPS study.. Journal of Clinical Oncology. 40(16_suppl). 5554–5554. 1 indexed citations
5.
Ferron, Gwénaël, Gaëtan De Rauglaudre, Pierre Combe, et al.. (2019). Impact of adding nintedanib to neoadjuvant chemotherapy (NACT) for advanced epithelial ovarian cancer (EOC) patients: The CHIVA double-blind randomized phase II GINECO study.. Journal of Clinical Oncology. 37(15_suppl). 5512–5512. 11 indexed citations
6.
Tod, Michel, Olivier Colomban, Isabelle Laure Ray-Coquard, et al.. (2019). Comparison of 11 circulating miRNAs and CA125 kinetics in ovarian cancer during first line treatment: Data from the randomized CHIVA trial (a GINECO-GCIG study). Annals of Oncology. 30. v783–v784. 1 indexed citations
7.
Freyer, Gilles, Benoît You, Stéphanie Villet, et al.. (2014). Open-label uncontrolled pilot study to evaluate complementary therapy with Ruta graveolens 9c in patients with advanced cancer. Homeopathy. 103(4). 232–238. 4 indexed citations
8.
Mrozek, Natacha, Salima Hamizi, F. Gourdon, et al.. (2008). Nocardiose disséminée nosocomiale probable après chirurgie prothétique ostéoarticulaire chez un patient immunocompétent. La Revue de Médecine Interne. 29(12). 1034–1037. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026